Literature DB >> 32450193

Symptom-based screening for COVID-19 in health care workers: The importance of fever.

Jean Cyr Yombi1, Julien De Greef2, Anne-Sophie Marsin3, Anne Simon4, Hector Rodriguez-Villalobos4, Andrea Penaloza5, Leila Belkhir2.   

Abstract

Entities:  

Keywords:  Fever; RT-PCR; SARS-CoV-2; respiratory symptoms; sensitivity; specificity

Year:  2020        PMID: 32450193      PMCID: PMC7242924          DOI: 10.1016/j.jhin.2020.05.028

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


× No keyword cloud information.
In December, 2019, a new acute respiratory syndrome appeared in Wuhan, China. The disease, later named COVID-19, is caused by a new coronavirus (SARS-CoV-2) [[1], [2], [3]]. Clinical presentation is mild in about 80%, moderate to severe in 15% and critical in 5% of cases [[1], [2], [3]]. The most common symptoms of COVID-19 are fever, fatigue, muscle pain, and dry cough [[1], [2], [3]]. Some patients may exhibit nasal congestion, chills, sore throat or diarrhoea [[1], [2], [3]]. In March 2020, interim Belgian guidelines recommended the screening only of symptomatic patients (fever and respiratory symptoms) who required hospitalization as well as of all healthcare workers (HCWs) with fever and respiratory symptoms [4]. We assessed the impact of using fever as a predictor for positivity of SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR). All of the results of RT-PCR for SARS-CoV-2 performed between 16th March 2020 and 24th April 2020 in HCWs in our tertiary hospital of 1000 beds were collected along with clinical symptoms (fever, respiratory symptoms consisting of dry cough, sore throat, shortness of breath). Two periods were analysed: Period 1, before 30th March 2020, during which HCWs were tested only if they had fever and respiratory symptoms (however, some physicians were tested without fever); and Period 2, after 30th March 2020, during which HCWs were tested if they had respiratory symptoms with or without fever. We included a total of 536 HCWs. Table I summarizes the clinical data during the two periods. During Period 1, 158 HCW were screened for SARS-CoV-2, including 50 with respiratory symptoms who were tested despite the absence of fever. Eighty-one (81/158, 51%) HCWs tested positive for SARS-Cov-2 (Table I). Among those who tested positive, 60/81 (74 %) had fever. During Period 2, of the 378 HCWs tested, only 94/378 (25 %) tested positive. Of those who tested positive, 49/94 (52%) had fever. Fever was present in only 63/284 (22%) of those who tested negative in Period 2. Finally, during the two periods studied, only 66/175 (38%) of non-febrile symptomatic HCWs tested positive.
Table I

Demographics and clinical characteristics of healthcare workers during two periods of screening

AllRT-PCR positiveRT-PCR negativeP
Before 30th March 2020
CharacteristicsN (%) = 158N (%) = 81 (51%)N (%) = 77 (49%)
Age <45 years111 (73%)49 (44%)62 (56%)0.52
Female125 (83%)58 (46%)67 (54%)0.90
Fever108 (68%)60 (56%)48 (44%)0.00
Cough121 (77%)63 (52%)58 (48%)0.04
Shortness of breath56 (35%)26 (46%)30 (54%)0.14
Sore throat98 (62%)45 (46%)53 (54%)0.04
Fever + cough80 (52%)47 (58%)33 (42%)0.00
Fever + cough + shortness of breath34 (23%)19 (58%)15 (47%)0.07
Fever + cough + sore throat48 (30%)25 (53%)23 (45%)0.52
After 30th March 2020
CharacteristicsN (%) = 37894 (25%)284 (75%)
Age <45 years213 (58%)50 (23%)163 (77%)0.98
Female253 (68%)60 (23%)197 (77%)0.00
Fever112 (30%)49 (44%)63 (56%)0.00
Cough244 (65%)73 (30%)171 (70%)0.01
Shortness of breath131 (35%)39 (30%)92 (70%)0.43
Sore throat190 (50%)46 (24%)144 (76%)0.78
Fever + cough68 (19%)38 (52%)32 (48%)0.00
Fever + cough + shortness of breath30 (8%)14 (46%)16 (54%)0.01
Fever + cough + sore throat44 (12%)23 (52%)21 (48%)0.03
Demographics and clinical characteristics of healthcare workers during two periods of screening Our results show that fever has a positive impact on the yield of RT-PCR for SARS-CoV-2. However, a proportion of COVID-19-positive cases, even when symptoms are combined, will be missed if fever is required as a criterion for testing. This was acknowledged by Chow et al. who recently showed that screening HCWs based on fever and respiratory symptoms is insufficient [5]. Among 48 symptomatic HCWs who tested positive for SARS-CoV-2, approximately 17% did not report fever, cough, shortness of breath, or sore throat. Among this group, chills, myalgia, coryza, and malaise were the most common symptoms. The researchers concluded that screening only for fever, cough, shortness of breath, or sore throat might have missed 17% of symptomatic HCWs and that adding criteria such as myalgia and chills may still have missed 10% [5]. These data are very interesting especially for HCWs working in home-care facilities or geriatric wards where an outbreak could have devastating effects on the fragile older population. It is important to note also that the difference in the RT-PCR positive rate between the two periods could also be attributed to hospital procedures adopted at the end of march consisting of universal mask wearing. Nonetheless, as shown in our results, the use of fever as a selection criterion led to an increased efficiency of screening. This is of particular interest in areas confronted with a shortage of testing materials, or to enable prioritized testing in the context of expanded SARS-CoV-2 testing strategies including low-risk symptomatic persons. [6].

Acknowledgements

The authors would like to thank Marina Andrade Pinto da Cunha for English editing.

Author contributions

Y.J.C., L.B., J.D.G. and A.S.M. designed the study and analysed the data. All of the authors wrote and revised the manuscript. All authors approved the final manuscript.

Conflict of interest statement

None declared.

Funding sources

None.
  4 in total

1.  Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington.

Authors:  Eric J Chow; Noah G Schwartz; Farrell A Tobolowsky; Rachael L T Zacks; Melinda Huntington-Frazier; Sujan C Reddy; Agam K Rao
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

  4 in total
  8 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

Review 2.  An Effective Mechanism for the Early Detection and Containment of Healthcare Worker Infections in the Setting of the COVID-19 Pandemic: A Systematic Review and Meta-Synthesis.

Authors:  Yueli Mei; Xiuyun Guo; Zhihao Chen; Yingzhi Chen
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

3.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2021-02-23

4.  Novel coronavirus seropositivity and related factors among healthcare workers at a university hospital during the prevaccination period: a cross-sectional study.

Authors:  Aziz Ogutlu; Oguz Karabay; Unal Erkorkmaz; Ertugrul Guclu; Seher Sen; Abdulkadir Aydin; Mehmet Koroglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-27       Impact factor: 3.944

5.  Difference in clinical features of SARS-CoV-2 in pediatric patients before and after emergence of P.1.

Authors:  Char Leung; Ka-Wah Khong; Kwok-Hung Chan; Marcus Vinicius Guimarães Lacerda; Carlos Henrique Michiles Frank
Journal:  Pediatr Res       Date:  2022-04-13       Impact factor: 3.953

6.  Mainstreaming the private health sector in the response to COVID-19: facility readinessassessment for screening services in Edo State, Nigeria.

Authors:  Darlington Ewaen Obaseki; Obehi Akoria; Esohe Olivia Ogboghodo; Otaniyenuwa Eloghosa Obarisiagbon; Ndubuisi Mokogwu; Orezimena Temitope Omo-Ikirodah; Funmilola Adio; Gregrey Agbonvihele Oko-Oboh; Sylvanus Okogbenin; Ekaete Tobin; Patrick Okundia; Osamwonyi Irowa; Uzor Okonmah
Journal:  Pan Afr Med J       Date:  2020-06-26

7.  Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study.

Authors:  Justyna Mika; Joanna Tobiasz; Joanna Zyla; Anna Papiez; Małgorzata Bach; Aleksandra Werner; Michał Kozielski; Mateusz Kania; Aleksandra Gruca; Damian Piotrowski; Barbara Sobala-Szczygieł; Bożena Włostowska; Paweł Foszner; Marek Sikora; Joanna Polanska; Jerzy Jaroszewicz
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

8.  Comparative Analysis of Circulating Levels of SARS-CoV-2 Antibodies and Inflammatory Mediators in Healthcare Workers and COVID-19 Patients.

Authors:  Luzia Maria de-Oliveira-Pinto; Victor Edgar Fiestas Solórzano; Maria de Lourdes Martins; Caroline Fernandes-Santos; Paula Hesselberg Damasco; Marilda Agudo Mendonça Teixeira de Siqueira; Helver Gonçalves Dias; Alex Pauvolid-Corrêa; Paulo Vieira Damasco; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-02-23       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.